SPDEF and chronic obstructive pulmonary disease: EGFR-mediated signaling is likely to be the predominant driver of airway remodeling and mucus cell hyperplasia in CS-induced COPD pathogenesis, and this pathway may not involve SPDEF-mediated mucous responses (11, 37).